Natural Beauty Bio-Technology Limited
NBBTF
$0.06
$0.00-6.90%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.26% | 38.95% | 69.03% | 69.62% | 13.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.26% | 38.95% | 69.03% | 69.62% | 13.41% |
| Cost of Revenue | 45.73% | 45.40% | 85.33% | 85.98% | 27.81% |
| Gross Profit | 34.05% | 33.74% | 57.96% | 58.51% | 3.96% |
| SG&A Expenses | 12.39% | 12.13% | 5.05% | 5.41% | 25.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -302.29% | -301.87% | 72.45% | 72.38% | 340.32% |
| Total Operating Expenses | 20.98% | 20.70% | 34.36% | 34.83% | 29.44% |
| Operating Income | 124.30% | 124.24% | 187.09% | 187.39% | -1,153.47% |
| Income Before Tax | 99.17% | 99.17% | 143.51% | 143.67% | -1,283.81% |
| Income Tax Expenses | 91.38% | 91.40% | -14.14% | -13.87% | -2,432.26% |
| Earnings from Continuing Operations | 99.52% | 99.52% | 135.95% | 136.07% | -1,189.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.52% | 99.52% | 135.95% | 136.07% | -1,189.10% |
| EBIT | 124.30% | 124.24% | 187.09% | 187.39% | -1,153.47% |
| EBITDA | 330.13% | 329.59% | 366.17% | 367.10% | -180.09% |
| EPS Basic | 100.00% | 100.00% | 140.00% | 140.00% | -1,100.00% |
| Normalized Basic EPS | 116.67% | 116.67% | 150.00% | 150.00% | -- |
| EPS Diluted | 100.00% | 100.00% | 140.00% | 140.00% | -1,100.00% |
| Normalized Diluted EPS | 116.67% | 116.67% | 150.00% | 150.00% | -- |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |